Related Experiment Video

Updated: May 18, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Leuprolide monotherapy for choroidal metastasis from prostate adenocarcinoma

Hossein Ameri1, John C Araujo, Dan S Gombos

  • 1Department of Ophthalmology and Visual Sciences, University of Texas Medical Branch, Galveston, TX, USA.

Archives of Ophthalmology (Chicago, Ill. : 1960)
|September 12, 2012
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser
07:17

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser

Published on: May 9, 2018

Related Experiment Videos

Last Updated: May 18, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser
07:17

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser

Published on: May 9, 2018

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Articles linked to this work by shared authors, journal, and citation graph.

Ultra-Widefield Fluorescein Angiography Findings in Patients With Retinitis Pigmentosa.

Journal of vitreoretinal diseases·2026

Acral lentiginous melanoma metastases to the vitreous masquerading as uveitis: A case report.

American journal of ophthalmology case reports·2026

Fundus autofluorescence imaging.

Handbook of clinical neurology·2026

Current Diagnosis and Management of Ocular Graft-Versus-Host Disease at a Tertiary Cancer Center.

Journal of clinical medicine·2026

Metastatic Uveal Melanoma Surveillance: A Delphi Panel Consensus.

Cancers·2026

Early genetic evolution of driver mutations in uveal melanoma.

Nature communications·2025

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value.

The American journal of managed care·2026

Induction Paclitaxel-Cisplatin-Capecitabine for Nasopharyngeal Carcinoma.

NEJM evidence·2026

Iron-Tannic Acid Hydrogel Mediated Mild Photothermal Therapy Combined With Ferroptosis Enhances Anti-Tumor Immunity in Colorectal Cancer.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

The evolution of new approaches to the treatment of congenital adrenal hyperplasia.

Endocrine reviews·2026

Acid-Suppressive Therapy in Inoperable Malignant Bowel Obstruction: A Systematic Review of the Available Evidence.

Journal of pain & palliative care pharmacotherapy·2026

Efficacy and safety of Heshu Xiaoji pills combined with standard treatment strategy in hepatitis B virus-related hepatocellular carcinoma: a single-center, open-label, prospective controlled, real-world cohort study.

Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us